Proof of Usefulness Report

Remedy Robotics

Analysis completed on 2/4/2026

+622
Proof of Usefulness Score
Category Standard

Remedy Robotics is a high-potential Series A medical technology company ($35M funding) that recently completed the world's first fully remote endovascular robotic surgeries (First-in-Human). While the project itself possesses exceptional utility and technical innovation, the submission provided contained factually incorrect claims (e.g., 'most people have used my product', 'everyone') which heavily penalized the Traction and Response Quality scores. The score reflects the company's verified external achievements adjusted for the poor quality of the provided input.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+237.5
Audience Reach Impact+60.0
Technical Innovation+142.5
Evidence Of Traction+106.3
Market Timing Relevance+90.0
Functional Completeness+2.5
Subtotal+638.8
Usefulness Multiplierx0.97
Final Score+622

Project Details

Description
Remedy Robotics is a medical technology company developing a remotely operated endovascular surgical robotic system. Their N1 system aims to revolutionize cardiovascular care by enabling physicians to perform life-saving interventions with enhanced precision and across vast distances. This technology seeks to expand access to critical treatments like mechanical thrombectomy for conditions such as stroke and heart attack, regardless of a hospital's onsite expertise [2, 4, 6].

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline